PK-DB: pharmacokinetics database for individualized and stratified computational modeling
Jan Grzegorzewski,Janosch Brandhorst,Kathleen Green,Dimitra Eleftheriadou,Yannick Duport,Florian Barthorscht,Adrian Köller,Danny Yu Jia Ke,Sara De Angelis,Matthias König,Danny Yu Jia Ke,Sara De Angelis
DOI: https://doi.org/10.1093/nar/gkaa990
IF: 14.9
2020-11-05
Nucleic Acids Research
Abstract:Abstract A multitude of pharmacokinetics studies have been published. However, due to the lack of an open database, pharmacokinetics data, as well as the corresponding meta-information, have been difficult to access. We present PK-DB (https://pk-db.com), an open database for pharmacokinetics information from clinical trials. PK-DB provides curated information on (i) characteristics of studied patient cohorts and subjects (e.g. age, bodyweight, smoking status, genetic variants); (ii) applied interventions (e.g. dosing, substance, route of application); (iii) pharmacokinetic parameters (e.g. clearance, half-life, area under the curve) and (iv) measured pharmacokinetic time-courses. Key features are the representation of experimental errors, the normalization of measurement units, annotation of information to biological ontologies, calculation of pharmacokinetic parameters from concentration-time profiles, a workflow for collaborative data curation, strong validation rules on the data, computational access via a REST API as well as human access via a web interface. PK-DB enables meta-analysis based on data from multiple studies and data integration with computational models. A special focus lies on meta-data relevant for individualized and stratified computational modeling with methods like physiologically based pharmacokinetic (PBPK), pharmacokinetic/pharmacodynamic (PK/PD), or population pharmacokinetic (pop PK) modeling.
biochemistry & molecular biology